Upgrade to SI Premium - Free Trial

Advaxis (ADXS) Gains on ADXS31-164 License to OS Therapies

September 4, 2018 8:49 AM
Advaxis, Inc. (NASDAQ: ADXS) gains 10% early after the company announced that Advaxis has granted a license to OS Therapies ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles